Observation on Therapeutic Effect of Lotus Needle Cupping Therapy for Removing Blood Stasis in Zhuang Medicine on PHN and Its Influ-ence on Inflammatory Mediators

[Objectives]To observe the clinical effect of the lotus needle cupping therapy for removing blood stasis in Zhuang medicine in treating PHNand its influence on inflammatory factors.[Methods]96 patients with PHN were randomly divided into three groups:lotus nee-dle cupping therapy group,TCM surrounding acupuncture group and gabapentin group.Venous blood and acupoint blood were collected at 0,21 and 42 d of treatment,and the expression levels of 5-HT,SP and CGRPinflammatory mediators were detected before and after treatment.The changes of VAS scores before,during and after treatment and the clinical efficacy were observed.[Results]The total effective rate of the lotus needle cupping group was 87.50%,which was better than that of the TCM acupuncture group(81.25%)and the gabapentin group(62.50%);after treatment,the VAS scores and the expression of inflammatory mediators in the three groups of patients were lower than those before treatment,and the decrease was more significant in the treatment group(P<0.05).[Conclusions]The lotus needle cupping therapy for removing blood stasis in Zhuang medicine is effective in treating PHN,and its mechanism is to reduce the release of inflammatory media-tors,reduce hyperalgesia,relieve pain and improve the quality of life of patients.

Clinical Observation on Influence of Chinese Medicines for Promoting Blood Circulation to Remove Blood Stasis on FIB and DD in Plasma of Patients with Cerebral Thrombosis

to study the influence of Chinese medicines for promoting blood circulation to remove blood stasis on fibrinogen(FIB)and D-dimer(DD)in plasma of patients with cerebral thrombosis. Method:73 inpatients with acute cerebral thrombosis were randomly divided into a control group of 34 cases and a treatment group of 39 cases.The content of FIB and DD in plasma was detected before treatment and on the 7th and 14th days after treatment.Result:FIB content in plasma after treatment was lower than that before treatment in the control group(P<0.01)and more remarkable in the treatment group(P<0.001).There was an obvious difference in DD content before and after treatment in both groups.DD content on the 7th and 14th days after treatment in the treatment group was obviously higher than that in the control group(P<0.01 and P<0.05 respectively). Conclusion:Chinese medicines for promoting blood circulation to remove blood stasis can reduce the FIB content in plasma of patients with cerebral thrombosis,raise the DD content in plasma, cause the peak of DD content appear earlier and obviously improve hypercoagulability of blood in patients with cerebral thrombosis.

Treatment of Hypertensive Cerebral Hemorrhage by Activating Blood Circulation to Remove Stasis

The treatment of hy-pertensive cerebral hemorrhage(HCH)by activatingblood circulation to removestasis(ABCRS)is a newtherapeutic approach,which is initiated by clinical specialists of TCM andintegrative Chinese andwestern medicine.Al-though it is not a flawless

Effect of Chinese Herbs for Activating Blood Circulation,Removing Stasis and Supplementing Qi on the Circulating Endothelial Cells in Patients with Unstable Angina Pectoris

Objective: To observe the effect and clinical significance of circulating endothelial cells (CEC) in the pathogenesis of coronary heart disease with unstable angina pectoris (CHD-UAP), and to explore the protective effect of Chinese herbs for activating blood circulation, removing stasis and supplementing Qi (CH) on CHD-UAP patient's CEC. Methods: Sixty patients with diagnosis of CHD-UAP confirmed and differentiated to be Qi-deficiency and blood stasis by TCM were randomly divided into two groups and treated, on the basis of Western drug-therapy, with Tongxinluo capsule (通心络胶囊, TXL) and Huoxue Tongmai capsule (活血通脉胶囊, HXTM) respectively by way of oral taking three times a day, 3 capsules every time, with 1 month as one therapeutic course. The number of CEC in patients' blood circulation was counted before and after treatment. Besides, the number of CEC in 30 healthy persons was also counted for control. Results: The number of CEC in CHD-UAP patients was significantly higher than that in the healthy persons (P<0.01). After the patients were treated with CH, either TXL or HXTM, it significantly decreased (P<0.01)with insignificant difference between the two treated groups. Conclusion: CEC in CHD-UAP patients is severely damaged and endothelial function in disorder, Chinese herbs have protective effect on patients' CEC.

Revealing the material basis of MMP9-mediated activating blood and removing blood stasis drugs on Danshen-Ligusticum chuanxiong anti- vascular effect

Objective:Reveal the material basis and mechanism of angiogenesis effect of Danshen-chuanxiong herb-partners.Methods:The effective components of Danshen and chuanxiong were searched in the TCM System Pharmacology Database(TCMSP),and the drug targets were searched in the Swiss Target Prediction database;in the Disease-Gene Database(DisGeNET))Search for angiogenesis-promoting and inhibiting angiogenesis targets;use the protein interaction database(STRING)database and Cytoscape software to analyze the network core targets;use the DAVID database to enrich the drug-disease target intersection for GO and KEGG;RT-qPCR experiments verified the effect of luteolin on MMP9 gene expression;in vitro tube formation experiments analyzed the effect of luteolin on endothelial cell neovascularization.Results:After analysis,it is concluded that Danshen has 10 active ingredients and 50 angiogenesis targets;Chuanxiong has 2 active ingredients and 4 angiogenesis targets.The intersection of drug-taking targets yielded 9 targets,including AR,PARP1,MMP9,MMP2,MMP12,AKR1B10,ABCC1,CDK6,and STAT3.After analyzing the active ingredient-target network graph of Danshen/Chuanxiong,it was concluded that luteolin is the key chemical ingredient.After protein interaction(PPI)analysis,the results showed that MMP9 is the core target.The KEGG pathway is mainly enriched in 5 signaling pathways,the most important pathway is cancer-related pathways.There are 22 main biological processes of GO,which mainly involve collagen catabolism,protein extracellular matrix,metal endopeptidase activity,etc.The preliminary analysis of tubule formation experiment shows that luteolin inhibits angiogenesis and down-regulates the expression of MMP9 gene.Conclusion:Luteolin,the key chemical component of the Danshen-Ligusticum chuanxiong drug pair,inhibits angiogenesis by regulating the MMP9 target,and develops the reverse regulation of angiogenesis for the traditional Chinese medicine for promoting blood circulation and removing blood stasis on the basis of the known treatment of ischemic diseases.Provide a new perspective and theoretical basis for the use of Danshen and Chuanxiong medicine in clinical cancer patients.Reveal the material basis and mechanism of angiogenesis effect of Danshen-chuanxiong herb-partners.

Research Progress and Research Ideas on Anti-hepatic Fibrosis and Promoting Blood Circulation and Removing Blood Stasis of the National Drug Plumbapin Based on TLR4 Signal Pathway

Hepatic fibrosis is a reversible pathological phenomenon in the early and middle stages,but but no satisfactory intervention drugs have been available so far.Recent studies have suggested that microcirculation disturbance of liver is one of the important pathogenesis of chronic liver disease,the improvement of microcirculation is beneficial to the recovery of liver function and the delay of liver fibrosis.Hepatic stellate cells are the core cells of hepatic fibrosis,and also the most critical cells that affect the microcirculation of the liver.While TLR4/MyD88/NF-κB and TLR4/MyD88/MAPKs which are based on the action of hepatic stellate cells are two pathways that have very important influence on the inflammatory response of liver,the proliferation and apoptosis of hepatic stellate cells,and the secretion of fibrogenic cytokines.It was found that Plumbapin,the active ingredient of Guangxi specialty ethnic medicine,has the definite effect of promoting blood circulation and removing blood stasis and anti-hepatic fibrosis,but its mechanism is not clear.In this study,the research progress of the above problems was reviewed,and further research ideas were derived as follows:the pharmacological effect of Plumbapin on anti-hepatic fibrosis,promoting blood circulation and removing stasis was based on the influence of TLR4/MyD88/NF-κB and MAPKs signal pathway.

Clinical Experience in the Treatment of Vitiligo by the Method of Invigorating Qi,Promoting Blood Circulation and Detoxification

Studies have shown that traditional Chinese medicines have clear curative effects in the treatment of vitiligo with few side effects.Through literature research and clinical observation,the study summarized the etiology and pathogenesis of vitiligo in traditional Chinese medicine as"deficiency,toxin,and stasis",formulated the method of invigorating qi,promoting blood circulation and detoxification,and prescribed Fuse Hexue Jiawei Decoction for the treatment of vitiligo.

Medication Rules of Traditional Chinese Medicine for Treating Threatened Abortion in the Early Stage of Pregnancy with Subchorionic Haematoma Based on Data Mining

Objective:Using data mining technology to explore the rules of traditional Chinese medicine(TCM)in the treatment of threatened abortion in the early stage of pregnancy with sub-chorionic haematoma(SCH).Methods:Literature of TCM in the treatment of threatened abortion in the early stage of pregnancy with SCH were retrieved from CNKI,VIP,WANFANG and Pubmed,EMBASE.The literature information database was established to be used for descriptive analysis,association rule analysis and cluster analysis of relevant data.Results:A total of 100 literatures were included,involving 114 Chinese herbs.The efficacy of Chinese herbs were mainly tonic drugs,hemostatic drugs,heat-clearing drugs,dissolving blood stasis and hemostatic drugs.The medicinal properties were mostly mild and warm,and the taste of the drug was mainly sweet,bitter and pungent.The liver meridian,spleen meridian and kidney meridian were frequently used.The commonly used drug pair combination was"Xu duan(Radix dipsaci,续断)-Tusizi(Semen Cuscutae,菟丝子)",and the core combination was"Tusizi-Xu duan-Ejiao(Donkeyhide gelatin,阿胶)-Baizhu(Atractylodes macrocephala,白术)-Dangshen(Codonopsis pilosula,党参)".Commonly used drugs for removing blood stasis and hemostasis were with Sanqi(Panax notoginseng,三七),Puhuang(cattail pollen,蒲黄),and Qiancao(Radix Rubiae,茜草).Conclusion:Data mining traditional Chinese medicine for the treatment of threatened abortion in the early stage of pregnancy with SCH clinically commonly used drug efficacy,taste,meridian,commonly used drug pairs,core combination and commonly used blood stasis hemostatic drugs,has important reference significance for the treatment of threatened abortion in the early stage of pregnancy combined with SCH.

活血化瘀治疗冠脉微循环障碍的研究进展

冠状动脉微循环障碍广泛存在于多种心血管疾病中,与左室重构、心血管事件密切相关。本病病机演变以血瘀为核心,活血化瘀法可改善患者冠状动脉血流储备及微循环阻力指数,对于冠状动脉微循环障碍具有良好的治疗效果。机制方面,活血化瘀诸法可调节冠状动脉微血管功能障碍的诸多关键病理生理环节:如,活血化瘀可有效抑制炎症、氧化应激及血栓形成;活血化痰可保护血管内皮;益气活血能改善能量代谢;补肾活血促进血管新生、建立冠脉侧支循环。应用现代科学深入挖掘活血化瘀诸法治疗本病的机制,或为解决本病治疗提供新的思路。

腰痛活血胶囊对强直性脊柱炎患者M1、M2型炎症因子的影响

目的探讨腰痛活血胶囊对强直性脊柱炎(AS)患者疗效及M1、M2型炎症因子的影响。方法选取2020年1月至2023年11月安徽中医药大学第一附属医院风湿科收治的60例AS患者,采用随机数字表法分为研究组、对照组各30例。研究组予腰痛活血胶囊(1.2 g,3次/d)联合沙利度胺口服(50 mg,每晚1次),对照组予沙利度胺口服(50 mg,每晚1次),2组均治疗4周。观察治疗前后疼痛视觉模拟评分法(VAS)评分、强直性脊柱炎疾病活动指数(BASDAI)评分、Bath强直性脊柱炎功能指数(BASFI)评分、Bath强直性脊柱炎计量学指数(BASMI)、Bath强直性脊柱炎总体指数(BAS-G)、中医临床证候积分及血清红细胞沉降率(ESR)、C反应蛋白(CRP)、M1型炎症细胞因子[肿瘤坏死因子(TNF)-α、白细胞介素(IL)-6]、M2型炎症细胞因子(IL-4、IL-10)的表达。结果2组治疗后,研究组和对照组的总有效率分别为90%及70%,研究组总有效率高于对照组,差异有统计学意义(P<0.05)。与治疗前相比较,研究组治疗后VAS、BASDAI、BASFI、BAS-G、BASMI、ESR、CRP、TNF-α、IL-6降低,腰骶脊背僵痛积分、腰脊活动受限积分、晨僵积分、夜间疼痛积分、关节肿痛积分及中医证候总积分降低,IL-4、IL-10表达升高(P<0.01)。与对照组治疗后相比较,研究组治疗后VAS、BASDAI、BASFI、CRP、IL-6、腰骶脊背僵痛、腰脊活动受限、夜间疼痛、中医证候总积分降低,IL-10表达升高(P<0.01)。结论腰痛活血胶囊联合沙利度胺可显著改善AS患者临床症状,通过上调M2型炎症因子表达,降低AS患者免疫炎症水平,改善患者临床症状且临床疗效安全。

基于“成骨-成血管耦联”理论探讨中医药防治激素性股骨头坏死的科学内涵

激素性股骨头坏死(steroid-induced necrosis of the femoral head, SNOFH)是骨科常见难治性疾病,又被视为“不死癌症”,若不及时干预将导致患者面临人工全髋关节置换术的风险。近些年研究证实,“成骨-成血管耦联”途径研究SNOFH发生发展的机制具有重要意义。SNOFH中医病机责之于脾肾亏虚为本,瘀血为病,痰阻为渐,毒聚为损。“成骨-成血管耦联”机制与“瘀去-新生-骨合”中医理论存在高度契合性。越来越多的临床证据表明中医药治疗SNOFH不仅具有疗效显著、不良反应小、价格低廉等优势,还能提高患者生存质量,为促进股骨头血管重建与再生以及股骨头坏死骨修复等发挥重要作用。基于“瘀去-新生-骨合”理论,临床上多采用补肾活血类中药及中药复方用于SNOFH防治,运用“成骨”之健脾补肾药,“成血管”之活血化瘀药,祛除“抑制因素”之化痰药、祛湿药,有步骤、有层次的治疗SNOFH取得显著效果。因此,从“成骨-成血管耦联”角度探讨SNOFH中医药干预的科学内涵已成为当今研究新热点,能够为后续SNOFH的防治研究和新药研发提供理论参考和借鉴。

李光荣活血化瘀学术思想治疗子宫内膜息肉探析

子宫内膜息肉可引起异常子宫出血、不孕,有恶变风险,术后易复发,影响女性的身心健康,属中医学“癥瘕”“不孕”范畴。李光荣教授认为女性多虚、多郁、多瘀,临床予活血化瘀学术思想治疗子宫内膜息肉。采用分级分时分类为原则的活血化瘀法,祛瘀求本、瘀湿同治、固护阴血,效果满意。

舌诊在慢性肝病中的应用刍议

舌诊作为中医特色诊法之一,在肝病的诊治与预防中具有重要意义。慢性肝病患者在不同的病理阶段有不同的舌象改变。舌色可反映肝病轻重缓急,如缓解期多见淡红舌,发作期多见红绛舌,而严重肝病多见青紫舌;舌形可反映肝病形气神,其中长条舌、圆柱舌是慢性肝病的常见舌形,舌缘肿大或者肝积舌多代表慢性肝病中的占位性病变;舌苔与肝病轻重及疾病预后有关,还可辅助诊断慢性肝病的细菌感染情况。此外,舌象在慢性肝病的临床用药指导中也具有重要意义,可多方面、多角度指导临床。

活血化瘀法在慢性原发免疫性血小板减少症辨治中的循证探索

目的:基于临床和中西医理论的整合,探索中医活血化瘀法在慢性原发免疫性血小板减少症(Primary Immune Thrombocytopenia,ITP)治疗中的临床应用循证依据。方法:结合临床总结分析中西医对ITP的病机认知,结合临床辨证和研究结果进行综合比照分析。结果:①慢性ITP虽然是以出血为主要表现的疾病,但是临床中仍然有发生血栓的现象,即出血与血栓的发生并存;②由中医学理论和临床辨证对ITP出血与瘀血状态的认识可知两者互为影响,验证了“离经止血,虽为清血,亦为瘀血”“瘀血不去,新血不生”的理论;③ITP的发生、发展过程中病机演化对瘀血形成的认识,提示了“久病多瘀”的证据;④中医药辨证论治的过程中,不失时机地选择应用活血化瘀法,不仅有效地治疗了ITP的出血症状,而且通过活血化瘀法还能够预防血栓的发生,提供了临床疗效证据。结论:基于临床疗效和ITP病机、病程的综合分析,中医活血化瘀法在慢性甚至是难治性ITP的治疗中不仅可以改善临床症状,还能够预防血栓的发生,为临床广泛应用提供很好的循证依据。部分患者的血小板水平也有提升。至于提升血小板的机制还有待于进一步的临床研究。

基于集合可视化分析名老中医王秀霞教授治疗卵巢巧克力囊肿患者的用药规律

目的:利用集合可视化分析系统探讨名老中医王秀霞治疗卵巢巧克力囊肿的学术思想及用药规律。方法:收集2017年9月1日至2018年12月31日黑龙江中医药大学附属医院王秀霞教授治疗卵巢巧克力囊肿的有效方剂,建立处方数据库,利用集合可视化分析王秀霞教授治疗卵巢巧克力囊肿的用药规律。结果:共纳入有效处方145首,涉及中药115味,分析处方中的常用药对及药物组合,演化得到新处方1首。结论:王教授治疗卵巢巧克力囊肿谨守“正虚邪实”的本质,在益肾疏肝的基础上,辅以化瘀、消癥之品,充分体现了“益肾疏肝为主兼顾化瘀消癥”的学术思想。

484例儿童大叶性肺炎临床资料回顾性分析

目的总结儿童大叶性肺炎的临床特点,分析中医药治疗本病的疗效,为临床诊治提供参考。方法对2021年3月至2024年2月在江苏省中医院儿科住院的484例大叶性肺炎患儿临床资料进行回顾性分析,总结大叶性肺炎的临床特点,通过分析退热时间、啰音消失时间、并发症的发生率、住院时间等探讨中医药治疗本病的优势。结果484例大叶性肺炎患儿男性236例、女性248例,发病年龄以2~10岁最为常见,多见于冬春季节。中医证型方面,痰热闭肺证和毒热闭肺证多见,共436例约占90.08%,风热闭肺证次之。中药组患儿治疗后退热时间、出院时咳嗽评分、啰音消失时间、住院天数、并发症的合并率明显低于对照组(P<0.05);化瘀中药组患儿在湿啰音消失时间、住院天数、出院时咳嗽评分、并发症的发生率方面明显低于基础中药组(P<0.05),有效率明显高于基础中药组和对照组(P<0.05)。结论在常规抗感染等治疗的基础上辨证加用中药治疗大叶性肺炎能促进啰音吸收、减少并发症发生、缩短病程;在常规中药的基础上加用活血化瘀之品疗效更佳。

活血化瘀类中药饮片与口服抗凝血药联合应用的出血风险研究

目的:探讨联合应用活血化瘀类中药饮片与口服抗凝血药治疗疾病的出血风险。方法:回顾性研究2022年该院服用口服抗凝血药和活血化瘀类中药饮片的住院患者158例,根据是否联合应用活血化瘀类中药饮片分为联合组(80例)和对照组(78例)。对照组患者使用的口服抗凝血药包括华法林、利伐沙班、达比加群酯;联合组患者联合应用的活血化瘀类中药饮片包括丹参、川芎、牛膝等。观察两组患者的凝血功能相关指标如凝血酶原时间-国际标准化比值(PT-INR)、纤维蛋白原(FIB)、D-二聚体(D-D)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)和出血事件发生率等。结果:联合组与对照组患者PT-INR、FIB、D-D、APTT和TT的差异均无统计学意义(P>0.05);联合组患者的出血事件发生率为66.25%(53/80),高于对照组的42.31%(33/78),差异有统计学意义(P<0.05)。结论:患者联合应用活血化瘀类中药饮片与口服抗凝血药后,虽然相关凝血指标并未出现明显变化,但是出血事件发生率显著升高。临床用药时,需重点关注含有丹参、川芎、牛膝和红花等的活血化瘀类中药饮片或中药复方制剂与口服抗凝血药联合应用会增加出血的风险。本研究为中西药相互作用研究提供了一定的借鉴。

温通化瘀散结法联合箍围-火针法治疗头部脓肿性穿掘性毛囊炎5例

目的分析头部脓肿性穿掘性毛囊炎的临床特征及中医证候特点,提高对本病的诊断及中医辨证水平。方法对5例头部脓肿性穿掘性毛囊炎的临床表现、中医证候、中医治则、方药、预后进行回顾性分析。结果5例患者均为青年男性,年龄为19~26岁,平均年龄22.62岁,5例患者皮损以头皮大量结节、囊肿、融合性脓肿为主,伴有明显脓性分泌物、压痛、脱发明显等临床特点。5例患者中2例肥胖(BMI≥30.0 kg/m 2)。5例患者皮疹辨证均符合痰瘀互结证。中医内治均采用温通化瘀散结之法,局部红肿者仙方活命饮加减。外治采用箍围-火针法,箍围使用自制消炎膏配合冲和散,火针针刺后按压排脓。中医药治疗时间为56~180 d,平均时间为101.20 d,5例中3例结节、囊肿完全消退,脓性分泌物消失,遗留色减斑及瘢痕(病例1~3);1例结节消失,囊肿变平,硬化性囊肿缩小(病例4);1例硬化性囊肿略缩小(病例5)。随访6个月后,2例肥胖患者均有复发,继续治疗后复发皮损消失。结论温通化瘀散结法联合箍围-火针法治疗头部脓肿性穿掘性毛囊炎临床疗效较好,值得进一步研究和推广。

活血化瘀涂搽药治疗冠脉介入穿刺并发症临床观察

目的观察活血化瘀涂搽药剂外敷治疗冠脉介入穿刺并发症的疗效。方法选取2021年1月1日—2022年12月31日在江西中医药大学附属医院行冠脉介入治疗后伴桡动脉穿刺点并发症的患者100例,随机分为试验组和对照组,各50例。对照组采用50%硫酸镁湿敷,试验组采用活血化瘀涂搽药剂湿敷,均连续治疗7 d,比较2组穿刺部位淤青面积变化、穿刺部位肿胀程度、穿刺部位疼痛程度及临床有效率。结果2组患者淤青面积、肿胀程度及疼痛评分均较治疗前降低(P<0.05),且试验组均低于对照组(P<0.05),试验组总有效率高于对照组(P<0.05)。结论活血化瘀涂搽药剂外敷相对于硫酸镁外敷更能有效减少冠脉介入穿刺并发症患者的淤青面积、肿胀程度及疼痛评分,提高临床有效率,疗效好,值得临床推广应用。

基于虚瘀理论探讨补虚化瘀法在药物不全流产中的应用

药物流产因操作简便且创伤小等诸多优点,常作为早期妊娠终止方式之一在临床广泛使用,但药物不全流产并发症严重影响了女性对药物流产的接受度,尤其当部分残留蜕膜组织滞留宫腔日久,且组织物较多或机化需要清宫处理时,更是对女性身心再次造成巨创。文章基于对药物流产过程及产后生理特点分析,认为流产时失血伤津、元气受损,发生不全流产的根本原因为冲任受损,血不收摄;瘀行不尽,停留胞宫;或因虚致瘀,瘀血内阻既是病理产物,又成为新的致病因素,呈现虚中兼瘀,虚实夹杂的特点。综上可知,药物不全流产的病机为产后虚损,瘀阻冲任。鉴于此,文章提出药物不全流产的治疗应以补虚化瘀为根本原则,主要治法:①补虚固本、补气养血,使冲任得固,同时补气兼行滞,以防因虚致瘀;②活血化瘀行滞,但不宜峻攻,也不可过早止血;③攻补兼施,补虚祛瘀,以补虚不留瘀为原则,通过补气养血,祛瘀生新,使旧血不滞,新血得宁。总之,结合药物不全流产病因病机特点,给予补虚化瘀治疗可促进残留妊娠组织排出及子宫复旧,减少不全流产的发生,兼顾保护女性生殖及身心健康、保护生育力方面,发挥了中医的独特优势。